Meningitis - Pipeline Analysis and Market Forecasts to 2016

Published by: GlobalData

Published: Mar. 5, 2010 - 39 Pages

Table of Contents

1 Table of contents

1.1 List of Tables

1.2 List of Figures

2 Meningitis: Market Characterization

2.1 Overview

2.2 Meningitis Market Size

2.3 Meningitis Market Forecast and CAGR

2.4 Drivers and Barriers for Meningitis Market

2.4.1 Drivers for Meningitis Market

2.4.2 Barriers for Meningitis Market

2.5 Opportunity and Unmet Need

2.6 Key Takeaway

3 Meningitis Market: Competitive Assessment

3.1 Overview

3.2 Strategic Competitor Assessment

3.3 Product Profile for the Major Marketed Products in Meningitis Market

3.3.1 Menactra

3.3.2 ActHIB

3.3.3 Merrem

3.3.4 AmBisome

3.4 Major Marketed Products Comparison in Meningitis Market

3.5 Key Takeaway

4 Meningitis Market: Pipeline Assessment

4.1 Overview

4.2 Strategic Pipeline Assessment

4.2.1 Technology Trends Analytical Framework

4.3 Meningitis - Promising Vaccines/Drugs under Clinical Development

4.4 Molecule Profile for Promising Vaccines/Drugs under Clinical Development

4.4.1 MenACWY

4.4.2 Meningitis B vaccine (MenB vaccine)

4.5 Meningitis Market - Clinical Pipeline by Vaccine Class

4.6 Meningitis Pipeline - Pipeline by Clinical Phases of Development

4.6.1 Meningitis - Phase III Clinical Pipeline

4.6.2 Meningitis - Phase II Clinical Pipeline

4.6.3 Meningitis - Phase I Clinical Pipeline

4.6.4 Meningitis - Discovery and Preclinical Pipeline

4.7 Discontinued / Suspended Products for Meningitis

4.8 Key Takeaway

5 Global Meningitis Market: Implications for Future Market Competition

6 Global Meningitis Market: Future Players in Meningitis Market

6.1 Introduction

6.2 Novartis

6.2.1 Company Overview

6.2.2 Business Description

6.2.3 Novartis - Infectious Diseases Pipeline

6.2.4 Novartis - Meningitis Vaccines Pipeline

6.3 GlaxoSmithKline

6.3.1 Company Overview

6.3.2 Business Description

6.3.3 GlaxoSmithKline - Infectious Diseases Pipeline

6.3.4 GlaxoSmithKline - Meningitis Pipeline

6.4 Sanofi-aventis

6.4.1 Company Overview

6.4.2 Business Description

6.4.3 Sanofi-aventis Infectious Diseases Pipeline

6.4.4 Sanofi-aventis - Meningitis Pipeline

6.5 InterMune Inc.

6.5.1 Company Overview

6.5.2 Business Description

6.5.3 InterMune - Infectious Diseases Pipeline

6.5.4 InterMune - Meningitis Pipeline

6.6 Merck & Co., Inc.

6.6.1 Company Overview

6.6.2 Business Description

6.6.3 Merck - Infectious Diseases Pipeline

6.6.4 Merck - Meningitis Pipeline

7 Global Meningitis Market: Appendix

7.1 Market Definitions

7.2 Abbreviations

7.3 Research Methodology

7.3.1 Coverage

7.3.2 Secondary Research

7.3.3 Forecasting

7.3.4 Primary Research

7.3.5 Expert Panel Validation

7.4 Contact Us

7.5 Disclaimer

7.6 Sources

1.1 List of Tables

Table 1: Global Meningitis Market, Revenues ($m), 2006-2016

Table 2: Major Marketed Products Comparison in Meningitis Market, 2010

Table 3: Meningitis - Most Promising Vaccines/Drugs Under Clinical Development, 2010

Table 4: Meningitis - Phase III Clinical Pipeline, 2010

Table 5: Meningitis - Phase II Clinical Pipeline, 2010

Table 6: Meningitis - Phase I Clinical Pipeline, 2010

Table 7: Meningitis - Discovery and Preclinical Pipeline, 2010

Table 8: List of Discontinued Products for Meningitis, 2010

Table 9: Novartis - Infectious Diseases Pipeline, 2010

Table 10: Novartis - Meningitis Pipeline, 2010

Table 11: GlaxoSmithKline - Infectious Diseases Pipeline, 2010

Table 12: GlaxoSmithKline - Meningitis Pipeline, 2010

Table 13: Sanofi-aventis - Infectious Diseases Pipeline, 2010

Table 14: Sanofi-aventis - Meningitis Pipeline, 2010

Table 15: InterMune - Infectious Diseases Pipeline, 2010

Table 16: InterMune - Meningitis Pipeline, 2010

Table 17: Merck - Infectious Diseases Pipeline, 2010

Table 18: Merck - Meningitis Pipeline, 2010

1.2 List of Figures

Figure 1: Global Meningitis Market Forecast, Revenues ($m), 2006-2016

Figure 2: Opportunity and Unmet Need in the Meningitis Market, 2010

Figure 3: Strategic Competitor Assessment of the Meningitis Market, 2010

Figure 4: Technology Trends Analytic Framework-Meningitis Market, 2010

Figure 5: Technology Trends Analytic Framework - Description- Meningitis Market, 2010

Figure 6: Meningitis Market - Clinical Pipeline by Class of Vaccine, 2010

Figure 7: Meningitis Pipeline by Phase of Clinical Development, 2010

Figure 8: Implications For Future Market Competition in the Meningitis Market, 2010

Figure 9: Meningitis Market - Clinical Pipeline by Company, 2010

Figure 10: GlobalData Methodology

Figure 11: GlobalData Market Forecasting Model

Abstract

• Annualized global meningitis disease market revenues data from 2006 to 2009, forecast forward for seven years to 2016.
• Geographic markets covered in this report include the US, Europe and Rest of the World.
• Pipeline analysis data providing a split across vaccines and drugs. Key vaccine classes include conjugated and recombinant vaccines.
• Analysis of the current and future market competition in the global meningitis market. Key market players covered are Novartis, GlaxoSmithKline, Sanofi-aventis (Sanofi Pasteur), InterMune and Merck.
• Insightful review of the key industry drivers, restraints and challenges. Each trend is independently researched to provide qualitative analysis of its implications.
• Key topics covered include strategic competitor assessments, market characterization, unmet needs and the implications for the future market associated with meningitis.

• Develop and design your in-licensing and out-licensing strategies through a review of the pipeline products and technologies and by identifying the companies with the most robust pipeline.
• Develop business strategies by understanding the trends shaping and driving the global meningitis market.
• Drive revenues by understanding the key trends, innovative products and technologies, market segments and companies likely to impact the global meningitis market in the future.
• Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the performance of various competitors.
• Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain the competitive advantage.
• Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships.
• What’s the next big thing in the global meningitis market landscape? Identify, understand and capitalize.

About MarketResearch.com
MarketResearch.com is an online aggregator selling over 300,000 market research reports, company profiles and country profiles from over 700 research firms. Our reports will provide you with the critical business and competitive intelligence you need for strategic planning and marketing research. Coverage includes the US, UK, Europe, Asia and global markets.